Your browser doesn't support javascript.
loading
A phase II/III double-blind, dose-finding clinical trial of a combination of mefloquine, sulfadoxine, and pyrimethamine (Fansimef) in falciparum malaria
Bull. W.H.O. (Print) ; 65(3): 357-361, 1987.
Article in English | WHO IRIS | ID: who-264448
Responsible library: CH1.1
Subject(s)

Full text: Available Collection: Databases of international organizations Health context: Neglected Diseases Health problem: Malaria / Neglected Diseases Database: WHO IRIS Main subject: Research Language: English Journal: Bull. W.H.O. (Print) Year: 1987 Document type: Article
Full text: Available Collection: Databases of international organizations Health context: Neglected Diseases Health problem: Malaria / Neglected Diseases Database: WHO IRIS Main subject: Research Language: English Journal: Bull. W.H.O. (Print) Year: 1987 Document type: Article
...